Table 3.
Multivariate-adjusted HRs for the development of type 2 diabetes associated with the number of metabolic syndrome components excluding IFG by the presence or absence of IFG
| FPG levels | No. of metabolic syndrome components excluding IFG | Population at risk (n) | No. events | Multivariate-adjusted HR (95%CI) | P trend |
|---|---|---|---|---|---|
| Normal | 0 | 285 | 12 | 1 (referent) | |
| 1 | 399 | 26 | 1.76 (0.88–3.50) | ||
| 2 | 236 | 22 | 2.49 (1.22–5.06) | ||
| 3 | 126 | 15 | 3.71 (1.72–8.02) | ||
| 4 | 40 | 7 | 5.90 (2.24–15.53) | <0.001 | |
| IFG | 0 | 122 | 13 | 1 (referent) | |
| 1 | 278 | 61 | 2.38 (1.30–4.35) | ||
| 2 | 243 | 62 | 2.98 (1.62–5.47) | ||
| 3 | 153 | 51 | 4.61 (2.48–8.56) | ||
| 4 | 53 | 17 | 4.22 (2.01–8.83) | <0.001 |
Data are n or HR (95% CI). Multivariate adjustment was made for age, sex, family history of diabetes, total cholesterol, alcohol intake, smoking habits, and regular exercise. Normal, FPG levels of <5.6 mmol/l; IFG, FPG levels of 5.6–6.9 mmol/l.